Results 81 to 90 of about 39,054 (209)

Sentinel lymph node biopsy in breast cancer

open access: yesSaudi Medical Journal, 2015
To report our experience in sentinel lymph node biopsy (SLNB) in early breast cancer. This is a retrospective study conducted at King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia between January 2005 and December 2014. There were 120 patients who underwent SLNB with frozen section examination.
openaire   +2 more sources

PREDICTORS OF QUALITY OF LIFE WITH AXILLARY REVERSE [PDF]

open access: yes, 2014
Breast cancer is the second most common cancer among women in the United States. Sentinel lymph node biopsy for staging early breast cancer in clinically node negative patients is supported by the American Society of Clinical Oncology due to a greater ...
Adkins, Barbara
core  

Sentinel node biopsy in early breast cancer patients with palpable axillary node [PDF]

open access: yes, 2020
Background: Sentinel lymph node biopsy is a reliable method for evaluation of the axillary lymph node status in early stage breast cancer patients with non-palpable lymph nodes.
Abedinnegad, S.   +7 more
core  

Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki   +6 more
wiley   +1 more source

Metastatic lymph nodes in the neck of patients with T1 and T2 squamous cell carcinoma of the lower lip detected with lymphoscintigraphy [PDF]

open access: yes, 2013
Aims and backgroundThe aim of our research was to use lymphoscintigraphy as a main method to confirm and detect lymph nodes in the neck, in patients with squamos cell carcinoma of lower lip which were clinically T1, T2 and N0, and to justify the use of ...
Agani, Zana   +4 more
core   +1 more source

Management training for hospital administrators: sentinel lymph-node biopsy under local anaesthetic for carcinoma of the breast–organizational and economic impact [PDF]

open access: yes
This study compares sentinel lymph-node biopsy carried out at the time of removal of the primary breast tumour, under general anaesthetic, with sentinel lymph-node biopsy carried out under local anaesthetic prior to the main operation.
Baraldi, S   +4 more
core   +2 more sources

Sentinel Lymph Node Biopsy in Breast Cancer

open access: yesWorld Journal of Oncology, 2010
The axillary lymph node status is the most reliable prognostic indicator of recurrence and overall survival in patients with breast cancer. The current standard surgical procedure for the management of invasive breast cancer is the complete removal of the cancer with total axillary clearance. However, recently, selective sentinel lymph node mapping and
openaire   +4 more sources

Cancer treatment and survivorship statistics, 2025

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle   +9 more
wiley   +1 more source

Biopsija limfnoga čvora „čuvara“ kod raka dojke; iskustvo stečeno u Klinici za tumore, Zagreb, Hrvatska [PDF]

open access: yes, 2003
The study was aimed at analyzing metastatic involvement in sentinel lymph node in patients with primary breast cancer. The study includes 51 female patients undergoing surgery for primary breast cancer at the University Hospital for Tumors, Zagreb ...
Juzbašić, Stjepan   +3 more
core   +1 more source

Comprehensive management of vulvovaginal cancers

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy